Not logged in Share Save
Share Save
Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024 Narjust Florez MD; Sandip Patel MD; Heather A. Wakelee MD; Julia Rotow MD; Elaine Shum MD; Jacob Sands MD; Ravi Salgia MD, PhD; Fred R. Hirsch MD, PhD; Solange Peters MD, PhD; Joshua Sabari MD; Hatim Husain MD; Lyudmila Bazhenova MD; Erminia Massarelli MD, PhD, MS; Leah M. Backhus MD, MPH; Percy Lee MD; Roy S. Herbst MD, PhD; Christine Bestvina MD; Kristin Higgins MD; Aakash Desai MD, MPH; Martin Dietrich MD, PhD; Hari Balaji Keshava MD, MS; Balazs Halmos MD, MS; David R. Gandara MD; Jonathan Wesley Riess MD, MS; Ana I. Velázquez MD, MSc; Anjali Sibley MD, MPH; Misty Shields MD, PhD; Triparna Sen PhD, MS; Edward S. Kim MD, MBA Share Save
Share Save
Molecular counting enables accurate and precise quantification of methylated ctDNA for tumor-naive cancer therapy response monitoring Ye, Patrick Peiyong; Viens, Robb; Shelburne, Katherine E.; Langpap, Sydne Scot; Bower, Xavier S.; Shi, Jonathan Jiahui; Zhou, Wen; Wignall, Jan Christian; Zhu, Joyce Jiawei; Woodward, Brian D.; Husain, Hatim; Tsao, David S.; Atay, Oguzhan Share Save
Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1 Wallen, Zachary D.; Nesline, Mary K.; Tierno, Marni; Roos, Alison; Schnettler, Erica; Husain, Hatim; Sathyan, Pratheesh; Caveney, Brian; Eisenberg, Marcia; Severson, Eric A.; Ramkissoon, Shakti H. Share Save
Share Save
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare KRAS mutations: a real-world retrospective study Jiang, Haohua; Li, Yujing; Wang, Yanan; Zou, Benkun; Chen, Ya; Zhang, Yanwei; Husain, Hatim; Forest, Fabien; Qian, Fangfei; Zhang, Lele; Zhou, Chao; Liu, Hongyu; Wang, Danni; Zhang, Wei; Lu, Jun; Han, Baohui Share Save
Share Save
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study Zhang, Dongming; Liu, Xiaoyan; Shen, Fangfang; Zhao, Dahai; Shi, Yuequan; Zhang, Haoran; Liu, Jia; Gao, Xiaoxing; Chen, Minjiang; Zhao, Jing; Zhong, Wei; Gao, Junzhen; He, Min; Liu, Yonggang; Yang, Xiaoling; Qin, Jianwen; Tang, Yuling; Mu, Xinlin; Gu, Yangchun; Zhang, Shucai; Chen, Xueqin; Pang, Li; Meng, Qingwei; Guo, Ye; Zhang, Yuhui; Li, Wei; Xing, Puyuan; Cheng, Yuan; Xin, Tao; Li, Qingxia; Li, Yu; Chen, Jun; Gao, Feng; Jin, Bo; Rossi, Antonio; Adachi, Hiroyuki; Guerrera, Francesco; Husain, Hatim; Xu, Yan; Wang, Mengzhao Share Save
Share Save
Methylated ctDNA dynamics correspond with clinical tumor load in metastatic lung cancer patients on therapy Ye, Patrick; Woodward, Brian; Viens, Robb; Langpap, Sydne; Shelburne, Katherine; Zhou, Wen; Zhu, Joyce; Wignall, Jan; Palmer, Gary; Tsao, David; Atay, Oguzhan; Husain, Hatim Share Save
Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study Ji, Jingran; Aredo, Jacqueline, V; Piper-Vallillo, Andrew; Huppert, Laura; Rotow, Julia K.; Husain, Hatim; Stewart, Susan; Cobb, Rosemary; Wakelee, Heather A.; Blakely, Collin M.; Wong, Melisa L.; Gubens, Matthew A.; Madani, Mohammad H.; Digumarthy, Subba R.; Mccoach, Caroline; Piotrowska, Zofia; Neal, Joel W.; Riess, Jonathan W. Share Save
Share Save
A phase 1b/2 study of PF-06747775 as monotherapy or in combination with Palbociclib in patients with epidermal growth factor receptor mutant advanced non-small cell lung cancer Cho, Byoung Chul; Goldberg, Sarah B.; Kim, Dong-Wan; Socinski, Mark A.; Burns, Timothy F.; Lwin, Zarnie; Pathan, Nuzhat; Ma, Wei Dong; Masters, Joanna C.; Cossons, Nandini; Wilner, Keith; Nishio, Makoto; Husain, Hatim Share Save
High-Dose Osimertinib for CNS Progression in EGFRþ NSCLC: A Multi-Institutional Experience Piper-Vallillo, A. J.; Rotow, Julia K.; Aredo, Jacqueline V.; Shaverdashvili, Khvaramze; Luo, Jia; Carlisle, Jennifer W.; Husain, Hatim; Muzikansky, Alona; Heist, Rebecca S.; Rangachari, Deepa; Ramalingam, Suresh S.; Wakelee, Heather A.; Yu, Helena A.; Sequist, Lecia V.; Bauml, Joshua M.; Neal, Joel W.; Piotrowska, Zofia Share Save
The efficacy of anlotinib as third-line treatment for non-small cell lung cancer by EGFR mutation status: a subgroup analysis of the ALTER0303 randomized phase 3 study Zhao, Yizhuo; Wang, Qiming; Zhang, Li; Shi, Jianhua; Wang, Zhehai; Cheng, Ying; He, Jianxing; Shi, Yuankai; Chen, Weiqiang; Luo, Yi; Wu, Lin; Wang, Xiuwen; Nan, Kejun; Jin, Faguang; Dong, Jian; Li, Baolan; Yamaguchi, Fumihiro; Breadner, Daniel; Nagano, Tatsuya; Tanaka, Fumihiro; Husain, Hatim; Li, Kai; Han, Baohui Share Save
Share Save
Share Save
Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients With Non-small Cell Lung Cancer Roosan, Moom R.; Mambetsariev, Isa; Pharaon, Rebecca; Fricke, Jeremy; Husain, Hatim; Reckamp, Karen L.; Koczywas, Marianna; Massarelli, Erminia; Bild, Andrea H.; Salgia, Ravi Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
